Inspire Medical SystemsINSP
紐約證券 · USD
58.41
-1.56
(-2.60%)
盤中 03/13 02:08 (UTC+8)
03/13 02:08 (UTC+8)
Inspire Medical SystemsINSP
58.41
-1.56
(-2.60%)
財務數據
損益表
- 1.53
- 1.93
- 1.64
- 1.96
- 2.03
- 2.40
- 2.01
- 2.17
- 2.25
- 2.69
- 1.46
- 25.57
- -14.80
- 19.43
- 3.73
- 17.98
- -16.02
- 7.83
- 3.42
- 19.86
- 營業收入(億)
- 季增長率(%)
單位：美元千元
2025/Q4 | 2025/Q3 | 2025/Q2 | 2025/Q1 | 2024/Q4 | 2024/Q3 | 2024/Q2 | 2024/Q1 | 2023/Q4 | 2023/Q3 | |
營業收入淨額 | 269,077 | 224,501 | 217,086 | 201,317 | 239,718 | 203,191 | 195,885 | 164,010 | 192,508 | 153,302 |
營業成本 | 36,071 | 31,773 | 34,672 | 30,709 | 35,988 | 32,398 | 29,843 | 24,757 | 28,054 | 24,382 |
營業毛利 | 233,006 | 192,728 | 182,414 | 170,608 | 203,730 | 170,793 | 166,042 | 139,253 | 164,454 | 128,920 |
營業費用 | 186,895 | 183,084 | 185,730 | - | 171,846 | 156,475 | - | 154,471 | 155,157 | 142,391 |
研發費用 | 24,942 | 24,211 | 26,209 | 27,803 | 30,336 | 26,083 | 28,859 | 28,850 | 31,052 | 29,144 |
推銷及管理費用 | 161,953 | 158,873 | 159,521 | 144,290 | 141,510 | 130,392 | 132,084 | 125,621 | 124,105 | 113,247 |
非經常性項目費用 | - | - | - | - | - | - | - | - | - | - |
其他營業費用 | - | - | - | - | - | - | - | - | - | - |
營業利益 | 46,111 | 9,644 | -3,316 | -1,485 | 31,884 | 14,318 | 5,099 | -15,218 | 9,297 | -13,471 |
其他收入及費用 | 4,330 | 3,918 | 988 | 5,644 | 4,774 | 6,008 | 5,747 | 5,863 | 5,943 | 5,271 |
利息費用 | 122 | 11 | 4 | - | 22 | - | - | - | - | - |
稅前純益 | 50,319 | 13,551 | -2,332 | 4,159 | 36,636 | 20,326 | 10,846 | -9,355 | 15,240 | -8,200 |
所得稅 | -85,771 | 3,619 | 1,260 | 1,167 | 1,412 | 1,829 | 1,053 | 650 | 477 | 340 |
稅後純益 | 136,090 | 9,932 | -3,592 | 2,992 | 35,224 | 18,497 | 9,793 | -10,005 | 14,763 | -8,540 |
基本每股稅後盈餘(元) | 4.70 | 0.34 | -0.12 | 0.10 | 1.18 | 0.62 | 0.33 | -0.34 | 0.50 | -0.29 |
稀釋每股稅後盈餘(元) | 4.58 | 0.33 | -0.12 | 0.10 | 1.15 | 0.61 | 0.33 | -0.34 | 0.51 | -0.29 |
基本平均股數(千股) | 28942.00 | 29332.00 | 29506.00 | 29702.00 | 29827.00 | 29879.00 | 29728.00 | 29615.00 | 29517.00 | 29365.00 |
稀釋平均股數(千股) | 29218.00 | 29600.00 | 29506.00 | 30311.00 | 30751.00 | 30633.00 | 30408.00 | 29615.00 | 30236.00 | 29365.00 |
還原基本每股稅後盈餘(元) | 4.70 | 0.34 | -0.12 | 0.10 | 1.18 | 0.62 | 0.33 | -0.34 | 0.50 | -0.29 |
還原稀釋每股稅後盈餘(元) | 4.58 | 0.33 | -0.12 | 0.10 | 1.15 | 0.61 | 0.33 | -0.34 | 0.51 | -0.29 |
還原基本平均股數(千股) | 28,942 | 29,332 | 29,506 | 29,702 | 29,827 | 29,879 | 29,728 | 29,615 | 29,517 | 29,365 |
還原稀釋平均股數(千股) | 29,218 | 29,600 | 29,506 | 30,311 | 30,751 | 30,633 | 30,408 | 29,615 | 30,236 | 29,365 |
EBITDA(千元) | 53,886 | 16,845 | 177 | 5,994 | 37,594 | 19,766 | 9,791 | -10,985 | 13,657 | -7,422 |